BevacizumabFirst report of posterior leukoencephalopathy syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2006年 / 1092卷 / 1期

关键词：

Bevacizumab; Adverse Drug Reaction; Blindness; Editorial Comment; Posterior Aspect;

D O I：

10.2165/00128415-200610920-00022

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：8 / 9

页数：1

相关论文

共 50 条

[41] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2009, 1264 (1) : 9 - 9
[42] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2008, 1198 (1) : 10 - 10
[43] TacrolimusReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2016, 1624 (1) : 163 - 163
[44] GemcitabineReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2009, 1272 (1) : 18 - 18
[45] SunitinibReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2013, 1444 (1) : 32 - 32
[46] RivoceranibReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2020, 1811 (1) : 242 - 242
[47] CytarabineReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2007, 1155 (1) : 8 - 8
[48] SirolimusReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2012, 1385 (1) : 40 - 40
[49] RituximabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2010, 1309 (1) : 36 - 36
[50] BevacizumabReversible posterior leukoencephalopathy syndrome: case report
[J]. Reactions Weekly, 2006, 1128 (1) : 8 - 8

← 1 2 3 4 5 →